Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -6-MTH group results

Oct 31 (Reuters)-  
             Taisho Pharmaceutical Holdings Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   6 months ended      6 months ended       Year to  
                  Sep 30, 2016        Sep 30, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              141.01              145.98           285.00     
                   (-3.4 pct)          (+2.9 pct)       (-1.8 pct)   
  Operating           16.66               13.93            29.50     
                   (+19.6 pct)         (-14.2 pct)      (+2.2 pct)   
  Recurring           19.13               17.68            36.50     
                   (+8.2 pct)          (-9.7 pct)       (-0.7 pct)   
  Net                 13.50               11.28            24.00     
                   (+19.7 pct)         (-10.4 pct)      (+6.8 pct)   
  EPS              168.93 yen          139.16 yen       300.37 yen   
  EPS Diluted      168.82 yen          139.09 yen                    
  Ann Div                              100.00 yen       110.00 yen   
  -Q2 div           50.00 yen           50.00 yen                    
  -Q4 div                               50.00 yen        60.00 yen   
   
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Taisho Pharmaceutical Holdings Co

See all news